LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Book ; Online: Tensor Decomposition of Large-scale Clinical EEGs Reveals Interpretable Patterns of Brain Physiology

    Gupta, Teja / Wagh, Neeraj / Rawal, Samarth / Berry, Brent / Worrell, Gregory / Varatharajah, Yogatheesan

    2022  

    Abstract: Identifying abnormal patterns in electroencephalography (EEG) remains the cornerstone of diagnosing several neurological diseases. The current clinical EEG review process relies heavily on expert visual review, which is unscalable and error-prone. In an ... ...

    Abstract Identifying abnormal patterns in electroencephalography (EEG) remains the cornerstone of diagnosing several neurological diseases. The current clinical EEG review process relies heavily on expert visual review, which is unscalable and error-prone. In an effort to augment the expert review process, there is a significant interest in mining population-level EEG patterns using unsupervised approaches. Current approaches rely either on two-dimensional decompositions (e.g., principal and independent component analyses) or deep representation learning (e.g., auto-encoders, self-supervision). However, most approaches do not leverage the natural multi-dimensional structure of EEGs and lack interpretability. In this study, we propose a tensor decomposition approach using the canonical polyadic decomposition to discover a parsimonious set of population-level EEG patterns, retaining the natural multi-dimensional structure of EEGs (time x space x frequency). We then validate their clinical value using a cohort of patients including varying stages of cognitive impairment. Our results show that the discovered patterns reflect physiologically meaningful features and accurately classify the stages of cognitive impairment (healthy vs mild cognitive impairment vs Alzheimer's dementia) with substantially fewer features compared to classical and deep learning-based baselines. We conclude that the decomposition of population-level EEG tensors recovers expert-interpretable EEG patterns that can aid in the study of smaller specialized clinical cohorts.

    Comment: 4 pages, 3 Figures, 2 Tables; Accepted at IEEE NER 2023
    Keywords Electrical Engineering and Systems Science - Signal Processing ; Computer Science - Machine Learning ; Statistics - Applications
    Subject code 616
    Publishing date 2022-11-24
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment.

    Gallacher, Peter J / Miller-Hodges, Eve / Shah, Anoop S V / Farrah, Tariq E / Halbesma, Nynke / Blackmur, James P / Chapman, Andrew R / Adamson, Philip D / Anand, Atul / Strachan, Fiona E / Ferry, Amy V / Lee, Kuan Ken / Berry, Colin / Findlay, Iain / Cruickshank, Anne / Reid, Alan / Gray, Alasdair / Collinson, Paul O / Apple, Fred S /
    McAllister, David A / Maguire, Donogh / Fox, Keith A A / Keerie, Catriona / Weir, Christopher J / Newby, David E / Mills, Nicholas L / Dhaun, Neeraj

    Kidney international

    2022  Volume 102, Issue 1, Page(s) 149–159

    Abstract: The benefit and utility of high-sensitivity cardiac troponin (hs-cTn) in the diagnosis of myocardial infarction in patients with kidney impairment is unclear. Here, we describe implementation of hs-cTnI testing on the diagnosis, management, and outcomes ... ...

    Abstract The benefit and utility of high-sensitivity cardiac troponin (hs-cTn) in the diagnosis of myocardial infarction in patients with kidney impairment is unclear. Here, we describe implementation of hs-cTnI testing on the diagnosis, management, and outcomes of myocardial infarction in patients with and without kidney impairment. Consecutive patients with suspected acute coronary syndrome enrolled in a stepped-wedge, cluster-randomized controlled trial were included in this pre-specified secondary analysis. Kidney impairment was defined as an eGFR under 60mL/min/1.73m
    MeSH term(s) Acute Coronary Syndrome ; Biomarkers ; Creatinine ; Female ; Humans ; Kidney ; Male ; Middle Aged ; Myocardial Infarction/blood ; Myocardial Infarction/complications ; Myocardial Infarction/diagnosis ; Myocardial Infarction/therapy ; Renal Insufficiency/blood ; Renal Insufficiency/complications ; Renal Insufficiency/diagnosis ; Troponin I/blood ; Troponin T
    Chemical Substances Biomarkers ; Troponin I ; Troponin T ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2022-03-07
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1016/j.kint.2022.02.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Risk factors for Coronavirus disease-associated mucormycosis.

    Arora, Umang / Priyadarshi, Megha / Katiyar, Varidh / Soneja, Manish / Garg, Prerna / Gupta, Ishan / Bharadiya, Vishwesh / Berry, Parul / Ghosh, Tamoghna / Patel, Lajjaben / Sarda, Radhika / Garg, Shreya / Agarwal, Shubham / Arora, Veronica / Ramprasad, Aishwarya / Kumar, Amit / Garg, Rohit Kumar / Kodan, Parul / Nischal, Neeraj /
    Singh, Gagandeep / Jorwal, Pankaj / Kumar, Arvind / Baitha, Upendra / Meena, Ved Prakash / Ray, Animesh / Sethi, Prayas / Xess, Immaculata / Vikram, Naval / Sinha, Sanjeev / Biswas, Ashutosh / Thakar, Alok / Bhatnagar, Sushma / Trikha, Anjan / Wig, Naveet

    The Journal of infection

    2021  Volume 84, Issue 3, Page(s) 383–390

    Abstract: Background: The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies.: Methods: We performed ...

    Abstract Background: The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies.
    Methods: We performed a case-control study comparing cases diagnosed with CAM and taking controls as recovered COVID 19 patients who did not develop mucormycosis. Information on comorbidities, glycemic control, and practices related to COVID-19 prevention and treatment was recorded. Multivariate regression analysis was used to identify independent predictors.
    Results: A total of 352 patients (152 cases and 200 controls) diagnosed with COVID-19 during April-May 2021 were included. In the CAM group, symptoms of mucormycosis began a mean of 18.9 (SD 9.1) days after onset of COVID-19, and predominantly rhino-sinus and orbital involvement was present. All, but one, CAM cases had conventional risk factors of diabetes and steroid use. On multivariable regression, increased odds of CAM were associated with the presence of diabetes (adjusted OR 3.5, 95% CI 1.1-11), use of systemic steroids (aOR 7.7, 95% CI 2.4-24.7), prolonged use of cloth and surgical masks (vs. no mask, aOR 6.9, 95%CI 1.5-33.1), and repeated nasopharyngeal swab testing during the COVID-19 illness (aOR 1.6, 95% CI 1.2-2.2). Zinc therapy was found to be protective (aOR 0.05, 95%CI 0.01-0.19). Notably, the requirement of oxygen supplementation or hospitalization did not affect the risk of CAM.
    Conclusion: Judicious use of steroids and stringent glycemic control are vital to preventing mucormycosis. Use of clean masks, preference for N95 masks if available, and minimizing swab testing after the diagnosis of COVID-19 may further reduce the incidence of CAM.
    MeSH term(s) COVID-19 ; Case-Control Studies ; Humans ; Mucormycosis/epidemiology ; Risk Factors ; SARS-CoV-2
    Language English
    Publishing date 2021-12-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2021.12.039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Clozapine-induced cardiomyopathy presenting as panic attacks.

    Sagar, Rajesh / Berry, Neeraj / Sadhu, Raja / Mishra, Sundeep / Kahn, David A

    Journal of psychiatric practice

    2008  Volume 14, Issue 3, Page(s) 182–185

    MeSH term(s) Adult ; Antipsychotic Agents/adverse effects ; Antipsychotic Agents/therapeutic use ; Bundle-Branch Block/chemically induced ; Bundle-Branch Block/diagnosis ; Cardiac Output, Low/chemically induced ; Cardiac Output, Low/diagnosis ; Cardiac Output, Low/psychology ; Cardiomyopathy, Dilated/chemically induced ; Cardiomyopathy, Dilated/diagnosis ; Cardiomyopathy, Dilated/psychology ; Clozapine/administration & dosage ; Clozapine/therapeutic use ; Diagnosis, Differential ; Electrocardiography, Ambulatory ; Follow-Up Studies ; Humans ; Male ; Panic Disorder/chemically induced ; Panic Disorder/diagnosis ; Panic Disorder/psychology ; Schizophrenia/diagnosis ; Schizophrenia/drug therapy ; Schizophrenic Psychology ; Treatment Outcome ; Ventricular Premature Complexes/chemically induced ; Ventricular Premature Complexes/diagnosis
    Chemical Substances Antipsychotic Agents ; Clozapine (J60AR2IKIC)
    Language English
    Publishing date 2008-05
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2022726-7
    ISSN 1538-1145 ; 1527-4160
    ISSN (online) 1538-1145
    ISSN 1527-4160
    DOI 10.1097/01.pra.0000320119.68928.68
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Molecular genetics of schizophrenia: a critical review.

    Berry, Neeraj / Jobanputra, Vaidehi / Pal, Hemraj

    Journal of psychiatry & neuroscience : JPN

    2003  Volume 28, Issue 6, Page(s) 415–429

    Abstract: We present an overview of current progress and future directions in the molecular genetics of schizophrenia. We review linkage studies, involving the genome-wide scan of chromosomes with closely spaced polymorphic markers, and association studies of ... ...

    Abstract We present an overview of current progress and future directions in the molecular genetics of schizophrenia. We review linkage studies, involving the genome-wide scan of chromosomes with closely spaced polymorphic markers, and association studies of candidate genes, identified on the basis of receptors, neurotransmitters and response to certain drugs. The limitations of the research methodology involved in analyzing such a complex disorder are discussed, as are methods to strengthen this methodology with newer statistical and technological advances to give results that are replicable, statistically significant and applicable to a wider population. A greater understanding of the genetic mechanisms and the application of pharmacogenetics would lead to improvements in therapeutic interventions.
    MeSH term(s) Chromosomes, Human, Pair 1/genetics ; Chromosomes, Human, Pair 15/genetics ; Chromosomes, Human, Pair 22/genetics ; Chromosomes, Human, Pair 6/genetics ; Genetic Markers ; Genetic Predisposition to Disease ; Genome, Human ; Humans ; Linkage Disequilibrium/genetics ; Molecular Biology/methods ; Point Mutation/genetics ; Polymorphism, Genetic/genetics ; Receptors, Dopamine D1/genetics ; Receptors, Dopamine D5 ; Receptors, GABA/genetics ; Receptors, N-Methyl-D-Aspartate/genetics ; Receptors, Serotonin/genetics ; Schizophrenia/drug therapy ; Schizophrenia/genetics ; Trinucleotide Repeats/genetics
    Chemical Substances DRD5 protein, human ; Genetic Markers ; Receptors, Dopamine D1 ; Receptors, GABA ; Receptors, N-Methyl-D-Aspartate ; Receptors, Serotonin ; Receptors, Dopamine D5 (137750-35-7)
    Language English
    Publishing date 2003-11
    Publishing country Canada
    Document type Journal Article ; Review
    ZDB-ID 1077443-9
    ISSN 1180-4882
    ISSN 1180-4882
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India

    Arora, Umang / Priyadarshi, Megha / Katiyar, Varidh / Soneja, Manish / Garg, Prerna / Gupta, Ishan / Bharadiya, Vishwesh / Berry, Parul / Ghosh, Tamoghna / Patel, Lajjaben / Sarda, Radhika / Garg, Shreya / Agarwal, Shubham / Arora, Veronica / Ramprasad, Aishwarya / Kumar, Amit / Garg, Rohit Kumar / Kodan, Parul / Nischal, Neeraj /
    Singh, Gagandeep / Jorwal, Pankaj / Kumar, Arvind / Baitha, Upendra / Meena, Ved Prakash / Ray, Animesh / Sethi, Prayas / Xess, Immaculata / Vikram, Naval Kishore / Sinha, Sanjeev / Biswas, Ashutosh / Thakar, Alok / Bhatnagar, Sushma / Trikha, Anjan / Wig, Naveet

    medRxiv

    Abstract: Background: The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies. Methods: We performed a ... ...

    Abstract Background: The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies. Methods: We performed a case-control study comparing cases diagnosed with CAM and those who had recovered from COVID-19 without developing mucormycosis (controls). Information on comorbidities, glycemic control, and practices related to COVID-19 prevention and treatment was recorded. Results: 352 patients (152 cases and 200 controls) diagnosed with COVID-19 during April-May 2021 were included. In the CAM group, symptoms of mucormycosis began a mean 18.9 (SD 9.1) days after onset of COVID-19, and predominantly rhino-sinus and orbital involvement was present. All, but one, CAM cases carried conventional risk factors of diabetes and steroid use. On multivariable regression, increased odds of CAM were associated with the presence of diabetes (adjusted OR 3.5, 95%CI 1.1-11), use of systemic steroids (aOR 7.7,95% CI 2.4-24.7), prolonged use of cloth and surgical masks (vs no mask, aOR 6.9, 95%CI 1.5-33.1), and repeated nasopharyngeal swab testing during the COVID-19 illness (aOR 1.6,95% CI 1.2-2.2). Zinc therapy, probably due to its utility in immune function, was found to be protective (aOR 0.05, 95%CI 0.01-0.19). Notably, the requirement of oxygen supplementation or hospitalization did not affect the risk of CAM. Conclusion: Judicious use of steroids and stringent glycemic control are vital to preventing mucormycosis. Use of clean masks, preference for N95 masks if available, and minimizing swab testing after the diagnosis of COVID-19 may further reduce the incidence of CAM.
    Keywords covid19
    Language English
    Publishing date 2021-07-26
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.07.24.21261040
    Database COVID19

    Kategorien

  7. Article: Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.

    Berry, Neeraj / Pradhan, Sapna / Sagar, Rajesh / Gupta, Suresh Kumar

    Pharmacotherapy

    2003  Volume 23, Issue 2, Page(s) 255–259

    Abstract: A 16-year-old boy developed fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium. When both drugs were discontinued, his fever and rigidity subsided ... ...

    Abstract A 16-year-old boy developed fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium. When both drugs were discontinued, his fever and rigidity subsided and biochemical irregularities spontaneously returned to normal, without any complications. Classic neuroleptic malignant syndrome (NMS) was diagnosed. Concomitant administration of lithium with olanzapine may place patients at risk for NMS. Clinicians need to be aware of this rare but potentially fatal side effect in patients of all ages, and especially in adolescents receiving both drugs.
    MeSH term(s) Adolescent ; Antipsychotic Agents/administration & dosage ; Antipsychotic Agents/adverse effects ; Benzodiazepines ; Bipolar Disorder/drug therapy ; Diagnosis, Differential ; Drug Therapy, Combination ; Humans ; Lithium/administration & dosage ; Lithium/adverse effects ; Male ; Neuroleptic Malignant Syndrome/diagnosis ; Neuroleptic Malignant Syndrome/etiology ; Olanzapine ; Pirenzepine/administration & dosage ; Pirenzepine/adverse effects ; Pirenzepine/analogs & derivatives
    Chemical Substances Antipsychotic Agents ; Benzodiazepines (12794-10-4) ; Pirenzepine (3G0285N20N) ; Lithium (9FN79X2M3F) ; Olanzapine (N7U69T4SZR)
    Language English
    Publishing date 2003-01-28
    Publishing country United States
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 603158-4
    ISSN 1875-9114 ; 0277-0008
    ISSN (online) 1875-9114
    ISSN 0277-0008
    DOI 10.1592/phco.23.2.255.32091
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top